CRL vs LPG · rev $2.00B vs P/E 8.8, rev $481.5M
Charles River Laboratories (CRL) versus Dorian LPG Ltd (LPG) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Dorian LPG Ltd (LPG) is a oil & gas midstream company listed on NYSE.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
Latest reported LPG revenue for 2026-03-31 was $481.5M. Net income was $193.7M. Revenue was up 534.5% from 2025-03-31 to 2026-03-31. LPG currently screens at market cap $1.71B and trailing P/E 8.8.
CRL currently screens at market cap $7.78B. LPG currently screens at market cap $1.71B and trailing P/E 8.8.
Not investment advice. Open the CRL and LPG stock pages for the full models.
Not investment advice.